Chemical transdifferentiation: closer to regenerative medicine
详细信息    查看全文
  • 作者:Aining Xu ; Lin Cheng
  • 刊名:Frontiers of Medicine
  • 出版年:2016
  • 出版时间:June 2016
  • 年:2016
  • 卷:10
  • 期:2
  • 页码:152-165
  • 全文大小:737 KB
  • 刊物主题:Medicine/Public Health, general;
  • 出版者:Springer Berlin Heidelberg
  • ISSN:2095-0225
  • 卷排序:10
文摘
Cell transdifferentiation, which directly switches one type of differentiated cells into another cell type, is more advantageous than cell reprogramming to generate pluripotent cells and differentiate them into functional cells. This process is crucial in regenerative medicine. However, the cell-converting strategies, which mainly depend on the virus-mediated expression of exogenous genes, have clinical safety concerns. Small molecules with compelling advantages are a potential alternative in manipulating cell fate conversion. In this review, we briefly retrospect the nature of cell transdifferentiation and summarize the current developments in the research of small molecules in promoting cell conversion. Particularly, we focus on the complete chemical compound-induced cell transdifferentiation, which is closer to the clinical translation in cell therapy. Despite these achievements, the mechanisms underpinning chemical transdifferentiation remain largely unknown. More importantly, identifying drugs that induce resident cell conversion in vivo to repair damaged tissue remains to be the end-goal in current regenerative medicine.Keywordscell therapycell transdifferentiationchemical compoundssmall moleculestissue regeneration

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700